Kirk Spano on bitcoin, options selling and a choppy 2025
Investing Experts
Investment Insights: Pfizer and Algonquin's Growth Potential
This chapter delves into prudent investment strategies by examining companies with a strong margin of safety, focusing on Pfizer and Algonquin. The discussion highlights Pfizer's attractive dividend yield and low-risk profile alongside Algonquin's growth potential driven by strategic changes and reduced debt.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
